Special Issue "Polypharmacy"
A special issue of Pharmacy (ISSN 2226-4787).
Deadline for manuscript submissions: closed (31 May 2020) | Viewed by 6997
Interests: polypharmacy; potentially inappropriate medications; multimorbidity; pharmacy practice; pharmacoepidemiology; artificial intelligence; causal inference; public health
Interests: pharmacoepidemiology; drug utilization research; polypharmacy; multimorbidity; mental health; medication adherence; care trajectories; administrative databases
The use of medications is at its highest level. The proportion of individuals taking multiple medications is concomitantly increasing in both older and younger populations. Nevertheless, this polypharmacy is still poorly understood. The wide variety of definitions used, the different combinations of medications that make it up, the heterogeneity of the diseases of the populations studied make it difficult to lay down clear conclusions about the prevalence of the condition and its associated impacts. However, it is essential to better understand polypharmacy and inappropriate prescriptions as well as their effects to ensure optimal care for individuals and to support health systems that are struggling under the pressure of sustained medication use.
We invite you to share your research on the broad topic of polypharmacy to improve knowledge about this condition. All aspects of polypharmacy, such as prevalence/incidence, determinants, impact of polypharmacy on health, economic considerations, and evaluation of interventions to reduce inappropriate prescriptions are welcome. We hope that this Special Issue will shed light on several unknowns related to polypharmacy to guide clinical practice and public health policies.
Prof. Caroline Sirois
Prof. Carlotta Lunghi
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Potentially inappropriate medications
- Older adults